PMN Promis Neurosciences Inc.

Fundamentals / CIK 0001374339 / USD

Promis Neurosciences Inc. reported $47.16M in total assets and a net loss of $38.81M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$6.93M$3.47M$0-$37.37MFY 2021 Net Income: -$9.79M2021FY 2022 Net Income: -$18.06M2022FY 2023 Net Income: -$13.21M2023FY 2024 Net Income: $2.78M2024FY 2025 Net Income: -$39.72M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $33.38M $10.64M $7.88M $16.09M $4.63M
Total Operating Expenses $40.17M $16.83M $14.26M $23.38M $8.29M
Operating Income -$40.17M -$16.83M -$14.26M -$23.38M -$8.29M
EBITDA -- -- -$14.24M -$23.37M -$8.25M
Interest Expense -- -- -- $282K $416K
Income Tax Expense -- $0 $0 $0 --
Net Income -$39.72M $2.78M -$13.21M -$18.06M -$9.79M
Basic EPS -$22.61 $2.68 -$26.75 -$60.25 -$42.25
Diluted EPS -$22.61 $2.63 -$26.75 -$60.25 -$42.25
Basic Shares Outstanding 1.8M 1.0M 491.7K 300.1K 231.4K
Diluted Shares Outstanding 1.8M 1.1M 491.7K 300.1K 231.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $6.71M $9.52M $6.97M $9.37M $9.80M $8.75M $5.46M $4.32M
Total Operating Expenses $8.62M $12.27M $8.64M $10.77M $11.75M $10.18M $7.46M $6.00M
Operating Income -$8.62M -$12.27M -$8.64M -$10.77M -$11.75M -$10.18M -$7.46M -$6.00M
Net Income -$8.16M -$11.73M -$8.24M -$10.67M -$11.58M -$10.12M -$7.35M -$238K
Basic EPS -$0.89 -$1.28 -$1.26 -- -$5.93 -$7.26 -$5.27 --
Diluted EPS -$0.89 -$1.28 -$1.26 -- -$5.93 -$7.26 -$5.27 --
Basic Shares Outstanding 9.1M 9.1M 6.5M -- 2.0M 1.4M 1.4M --
Diluted Shares Outstanding 9.1M 9.1M 6.5M -- 2.0M 1.4M 1.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $6.12M $13.29M $12.60M $5.88M $16.94M
Short-Term Investments $34K $33K $32K $31K $33K
Cash & Short-Term Investments $6.15M $13.32M $12.63M $5.91M $16.98M
Total Current Assets $9.18M $18.91M $13.62M $6.90M $17.71M
Property, Plant & Equipment, Net -- -- -- $321 $4.7K
Intangible Assets -- -- -- $21K $28K
Total Non-Current Assets $0 $0 $0 $21K $32K
Total Assets $9.18M $18.91M $13.62M $6.92M $17.75M
Accounts Payable $2.54M $1.74M $7.84M $2.98M $409K
Total Current Liabilities $10.41M $2.22M $9.35M $6.41M $929K
Long-Term Debt -- -- $0 -- $3.91M
Total Non-Current Liabilities $29K $205K $516K $1.86M $11.16M
Total Liabilities $10.44M $2.42M $9.87M $8.27M $12.09M
Total Debt (incl. Leases) -- -- $0 -- $3.91M
Common Stock -- -- -- -- $0
Retained Earnings -$130.4M -$90.69M -$93.47M -$80.25M -$62.19M
Accumulated Other Comp. Income -$371K -$371K -$371K -$195K -$188K
Total Stockholders' Equity -$1.26M $16.49M $3.75M -$1.35M $5.66M
Total Equity -$1.26M $16.49M $3.75M -$1.35M $5.66M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $44.07M $53.43M $63.81M $6.12M $15.40M $4.51M $8.36M $13.29M
Short-Term Investments $34K $34K $34K $34K $33K $33K $33K $33K
Cash & Short-Term Investments $44.11M $53.46M $63.85M $6.15M $15.43M $4.54M $8.40M $13.32M
Total Current Assets $47.16M $56.69M $65.61M $9.18M $21.46M $9.51M $13.65M $18.91M
Total Non-Current Assets $0 $0 $1.80M $0 $0 $0 $0 $0
Total Assets $47.16M $56.69M $67.41M $9.18M $21.46M $9.51M $13.65M $18.91M
Accounts Payable $485K $1.79M $1.72M $2.54M $4.21M $2.78M $1.20M $1.74M
Total Current Liabilities $5.34M $7.22M $6.61M $10.41M $12.21M $9.82M $4.06M $2.22M
Total Non-Current Liabilities $56K $77K $79K $29K $60K $68K $119K $205K
Total Liabilities $5.40M $7.29M $6.69M $10.44M $12.27M $9.89M $4.17M $2.42M
Retained Earnings -$158.5M -$150.4M -$138.7M -$130.4M -$119.7M -$108.2M -$98.03M -$90.69M
Accumulated Other Comp. Income -$371K -$371K -$371K -$371K -$371K -$371K -$371K -$371K
Total Stockholders' Equity $41.76M $49.40M $60.72M -$1.26M $9.19M -$383K $9.47M $16.49M
Total Equity $41.76M $49.40M $60.72M -$1.26M $9.19M -$383K $9.47M $16.49M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$39.72M $2.78M -$13.21M -$18.06M -$9.79M
Depreciation & Amortization -- -- $21K $11K $46K
Stock-Based Compensation $858K $826K $272K $488K $516K
Change in Payables $806K -$6.11M $4.96M $2.68M -$32K
Operating Cash Flow -$28.12M -$27.18M -$10.84M -$17.03M -$9.31M
Capital Expenditure -- -- -- -$2.0K -$6.0K
Free Cash Flow -- -- -- -$17.04M -$9.31M
Investing Cash Flow -$702 -$693 -$1.3K -$2.0K $95K
Common Stock Issued $708K $190K -- $4.97M $15.87M
Financing Cash Flow $20.94M $27.88M $17.75M $6.49M $25.52M
Net Change in Cash -$7.17M $693K $6.72M -$11.07M $16.14M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$8.16M -$11.73M -$8.24M -$10.67M -$11.58M -$10.12M -$7.35M -$238K
Stock-Based Compensation $483K $409K $189K $203K $197K $212K $245K $623K
Change in Payables -$1.31M $77K -$827K -$1.67M $1.43M $1.58M -$537K $162K
Operating Cash Flow -$9.38M -$10.39M -$12.38M -$9.28M -$10.06M -$3.85M -$4.93M -$8.72M
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow $21K $0 $70.08M -- -- -- -- $470K
Net Change in Cash -$9.36M -$10.39M $57.70M -$9.28M $10.89M -$3.85M -$4.93M -$8.25M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- 16.9% -352.0% -- -173.0%
Return on Assets (ROA) -432.6% 14.7% -97.0% -260.8% -55.2%
Current Ratio 0.88x 8.52x 1.46x 1.08x 19.07x
Quick Ratio 0.59x 6.01x 1.35x 0.92x 18.27x
Debt to Equity -- -- 0.00x -- 0.69x
Net Income Growth (YoY) -1529.3% -- -- -- --
EPS Growth (YoY) -943.7% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -92.9% -85.5% -66.9% -- -318.7% -- -9.9% 16.9%
Return on Assets (ROA) -82.3% -74.5% -60.3% -432.6% -136.5% -88.6% -6.8% 14.7%
Current Ratio 8.83x 7.85x 9.92x 0.88x 1.76x 0.97x 3.36x 8.52x
Quick Ratio 8.26x 7.41x 9.65x 0.59x 1.26x 0.46x 2.07x 6.01x
Net Income Growth (YoY) -- -- -- -- -224.8% -- -- --
EPS Growth (YoY) -- -- -- -- -176.5% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001374339) · from June 30, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal